4.8 Article

BRCA1 Haploinsufficiency Is Masked by RNF168-Mediated Chromatin Ubiquitylation

期刊

MOLECULAR CELL
卷 73, 期 6, 页码 1267-+

出版社

CELL PRESS
DOI: 10.1016/j.molcel.2018.12.010

关键词

-

资金

  1. Salvador Madariaga Program from the Spanish Ministry of Education, Culture and Sports [PRX18/00364]
  2. Intramural Research Program of the NIH
  3. Ellison Medical Foundation Senior Scholar in Aging Award [AG-SS-2633-11]
  4. Department of Defense [W81XWH-15-2-006, W81XWH-16-1-599]
  5. Alex Lemonade Stand Foundation Award
  6. NIH Intramural FLEX Award
  7. Rutgers Cancer Institute
  8. NCI-CCR Partnership on DNA Repair and Genomic Instability in Cancer
  9. NATIONAL CANCER INSTITUTE [ZIABC010959] Funding Source: NIH RePORTER

向作者/读者索取更多资源

BRCA1 functions at two distinct steps during homologous recombination (HR). Initially, it promotes DNA end resection, and subsequently it recruits the PALB2 and BRCA2 mediator complex, which stabilizes RAD51-DNA nucleoprotein filaments. Loss of 53BP1 rescues the HR defect in BRCA1-deficient cells by increasing resection, suggesting that BRCA1's downstream role in RAD51 loading is dispensable when 53BP1 is absent. Here we show that the E3 ubiquitin ligase RNF168, in addition to its canonical role in inhibiting end resection, acts in a redundant manner with BRCA1 to load PALB2 onto damaged DNA. Loss of RNF168 negates the synthetic rescue of BRCA1 deficiency by 53BP1 deletion, and it predisposes BRCA1 heterozygous mice to cancer. BRCA1(+/-) RNF168(-/-) cells lack RAD51 foci and are hypersensitive to PARP inhibitor, whereas forced targeting of PALB2 to DNA breaks in mutant cells circumvents BRCA1 haploinsufficiency. Inhibiting the chromatin ubiquitin pathway may, therefore, be a synthetic lethality strategy for BRCA1-deficient cancers.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据